龍元建設(600491.SH):不超8.05億元應收賬款資產支持專項計劃資產支持證券掛牌轉讓獲無異議函
格隆匯2月18日丨龍元建設(600491.SH)公佈,2020年2月18日,公司收到上海證券交易所《關於對五礦-龍元建設應收賬款資產支持專項計劃資產支持證券掛牌轉讓無異議的函》上證函[2020]239號,五礦-龍元建設應收賬款資產支持專項計劃資產支持證券發行總額不超過8.05億元。無異議函自出具之日起12個月內有效。公司應在無異議函有效期內按照報送上交所的相關文件完成發行。
此次募集資金主要用於支持疫情防控項目、償還金融機構借款,以及補充公司流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.